🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsCompounding & FormulationNeedle gauge and dead space — March 2026 Page 4

Needle gauge and dead space — March 2026

TirzTom Sun, Mar 9, 2025 at 6:46 PM 49 replies 2,557 viewsPage 4 of 10
mia_MS2
New Member
8
23
Mar 2026
Ann Arbor, MI
Mar 10, 2025 at 12:26 AM#16

Just wanted to say — for anyone reading this Needle gauge and thread who is feeling discouraged: it gets better. The first few weeks are the hardest. Hang in there. 💪

35 7ricardo_MIA, BrianDallas92, labquiet_amy and 32 others
Reply Quote Save Share Report
LondonLisa
Member
912
3,456
Mar 2024
London, UK
Mar 10, 2025 at 12:43 AM#17

TirzTom's experience with Needle gauge and dead resonates deeply with mine. I went through almost the identical process — starting dose, titration timeline, side effects, everything.

The main difference: I started 3 months later. But the overall trajectory has been remarkably similar. Down 54 lbs in 9 months.

One thing I would add that TirzTom did not mention: the mental health improvements were just as significant.

35 0Dr.MetabolicMD, RetaRick_CA, JenPlateau and 32 others
Reply Quote Save Share Report
nick_newbie
New Member
18
56
Mar 2026
Virginia
Online
Mar 10, 2025 at 1:00 AM#18

Saving this for reference. Top-tier content.

Last edited: Mar 10, 2025 at 4:00 AM
50 19MeganSA_TX, LarryQC_SD, wanda_boise and 47 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
james_edin
Member
289
1,234
Sep 2024
Edinburgh, UK
Mar 10, 2025 at 1:17 AM#19

As a pharmacist, I want to add some clinical context to this discussion on Needle gauge and dead space March 2026.

Building on what TirzTom said — the evidence base here is robust. The key publications to reference are from the SURMOUNT program[1].

Key clinical points:

  1. Efficacy is dose-dependent and typically requires 4-5 weeks to reach steady state
  2. Side effect profile is predictable and usually manageable with standard protocols
  3. Monitoring should include baseline labs and follow-up at 3-month intervals
  4. Patient education significantly improves outcomes and adherence

Standard disclaimer: this is educational, not individualized medical advice.

References:
[1] See thread title for relevant study identification.
20 1oliver_london, tane_welly, Dr.PathRoch and 17 others
Reply Quote Save Share Report
FDA_TrackerJim
Senior Member
1,567
7,890
Feb 2024
Rockville, MD
Mar 10, 2025 at 1:34 AM#20

Subscribing to this thread. Needle gauge and dead is exactly what I've been researching. 🙏

Last edited: Mar 10, 2025 at 4:34 AM
23 2jason_paloalto, Dr.LeslieOBGYN, MikeNYC_runner and 20 others
Reply Quote Save Share Report

Similar Threads

503A vs 503B compounding — regulatory framework explained4 replies
Compounded semaglutide stability: accelerated degradation study results6 replies
Lyophilized vs liquid peptides — stability and bioavailability comparison18 replies
Bacteriostatic water sourcing and sterility considerations8 replies
State-by-state compounding pharmacy regulations — 2026 map8 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register